IP Library Granted Patent US 11,484,521
Granted Patent B2
US 11,484,521 · App. 16/604,510 · Granted Nov 1, 2022

Antidotes to cyanide poisoning

Inventors: Randall Peterson (Stoneham, MA); Robert Gerszten (Brookline, MA); Anjali Nath (Boston, MA); Calum MacRae (Wellesley Hills, MA); Gerry Boss (La Jolla, CA); Matt Brenner (Irvine, CA); Sari Brenner Mahon (Irvine, CA)
Assignees: The General Hospital Corporation; The Regents of the University of California
A61K31/282A61P39/02A61K9/0019
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,484,521
App. No.
16/604,510
Granted
Nov 1, 2022
Kind
B2
Abstract

The present application provides, inter alia, a compound of Formula (I): or a pharmaceutically acceptable salt thereof, and methods of use of the compound of Formula (I) for treatment and prevention of cyanide poisoning.

Claims (16)

1. A unit dosage form comprising:

(i) a compound selected from:

or a pharmaceutically acceptable salt thereof, and

(ii) a pharmaceutically acceptable carrier,

wherein the unit dosage form is in the form of a tablet, capsule, or ampule suitable for direct administration to a subject, and

wherein the unit dosage form comprises a therapeutically effective amount to provide protection against cyanide poisoning.

2. The pharmaceutical composition of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

3. The pharmaceutical composition of claim 2 , wherein the compound is selected from:

4. The pharmaceutical composition of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

5. The pharmaceutical composition of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

6. The pharmaceutical composition of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

7. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition is suitable for administration by an intramuscular injection.

Assignments (4)
CONFIRMATORY LICENSE Recorded Oct 12, 2022
From: MASSACHUSETTS GENERAL HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061387/0438 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2021
From: BOSS, GERRY; BRENNER, MATTHEW; MAHON, SARI BRENNER
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 058506/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2021
From: PETERSON, RANDALL; MACRAE, CALUM
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 058509/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2020
From: GERSZTEN, ROBERT; NATH, ANJALI
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 053843/0247 →
Continuity (2)
Provisional Application 62484623 · Apr 12, 2017
Related Publication 20200276148A1 · Sep 3, 2020